Neoadjuvant Intraperitoneal Chemotherapy in Patients with Pseudomyxoma Peritonei—A Novel Treatment Approach

Neoadjuvant Intraperitoneal Chemotherapy in Patients with Pseudomyxoma Peritonei—A Novel Treatment Approach

Neoadjuvant intravenous chemotherapy in patients with pseudomyxoma peritonei (PMP) has not shown convincing results. The effectiveness of neoadjuvant intraperitoneal (IP) chemotherapy has never been reported. This prospective, non-randomized phase II study included patients with PMP treated between...

Full description

Bibliographic Details
Main Authors: Aruna Prabhu, Andreas Brandl, Satoshi Wakama, Shouzou Sako, Haruaki Ishibashi, Akiyoshi Mizumoto, Nobuyuki Takao, Kousuke Noguchi, Shunsuke Motoi, Masumi Ichinose, Yang Liu, Yutaka Yonemura
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Cancers
Subjects:
pseudomyxoma peritonei
neoadjuvant intraperitoneal chemotherapy
cytoreductive surgery
hyperthermic intraperitoneal chemotherapy
pathological response
Online Access:https://www.mdpi.com/2072-6694/12/8/2212

Internet

https://www.mdpi.com/2072-6694/12/8/2212

Similar Items